# A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants

> **NCT04493255** · PHASE1 · COMPLETED · sponsor: **Eisai Limited** · enrollment: 8 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** [14C]E7090

## Key facts

- **NCT ID:** NCT04493255
- **Lead sponsor:** Eisai Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-09
- **Primary completion:** 2020-10-21
- **Final completion:** 2020-10-21
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2021-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04493255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04493255, "A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04493255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*